Correlation Between NervGen Pharma and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NervGen Pharma Corp and NervGen Pharma Corp, you can compare the effects of market volatilities on NervGen Pharma and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and NervGen Pharma.

Diversification Opportunities for NervGen Pharma and NervGen Pharma

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between NervGen and NervGen is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and NervGen Pharma go up and down completely randomly.

Pair Corralation between NervGen Pharma and NervGen Pharma

Assuming the 90 days trading horizon NervGen Pharma Corp is expected to generate 0.98 times more return on investment than NervGen Pharma. However, NervGen Pharma Corp is 1.02 times less risky than NervGen Pharma. It trades about 0.04 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.02 per unit of risk. If you would invest  252.00  in NervGen Pharma Corp on September 12, 2024 and sell it today you would earn a total of  12.00  from holding NervGen Pharma Corp or generate 4.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

NervGen Pharma Corp  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
NervGen Pharma Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.
NervGen Pharma Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

NervGen Pharma and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NervGen Pharma and NervGen Pharma

The main advantage of trading using opposite NervGen Pharma and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind NervGen Pharma Corp and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities